作者：
Matthew,Mossanen [1]
;
Amin H,Nassar [2]
;
Samantha M,Stokes [3]
;
Nieves,Martinez-Chanza [4]
;
Vivek,Kumar [2]
;
Pier Vitale,Nuzzo [4]
;
David J,Kwiatkowski [5]
;
Judy E,Garber [3]
;
Catherine,Curran [4]
;
Dory,Freeman [4]
;
Mark,Preston [1]
;
Kent W,Mouw [4]
;
Adam,Kibel [1]
;
Toni K,Choueiri [4]
;
Guru,Sonpavde [6]
;
Huma Q,Rana [7]
作者单位：
Department of Urology, Brigham and Women's Hospital, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA.
[1]
Department of Medicine, Brigham and Women's Hospital, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA.
[2]
Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA.
[3]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA.
[4]
Department of Medicine, Section of Medical Oncology, Brigham and Women's Hospital, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA.
[5]
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA. Electronic address: gurup_sonpavde@dfci.harvard.edu.
[6]
Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA. Electronic address: HumaQ_Rana@DFCI.HARVARD.EDU.
[7]
DOI
10.1016/j.clgc.2022.08.009
PMID
36127252
发布时间
2023-01-08
换一批
换一批
